- idUS
- Listar por autor
Listar por autor "Delgado-Valverde, Mercedes"
Mostrando ítems 1-4 de 4
-
Artículo
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
Cañada García, Javier E.; Moure, Zaira; Sola Campoy, Pedro J.; Delgado-Valverde, Mercedes; Cano, María E.; Gijón, Desirée; Pascual Hernández, Álvaro; Oteo Iglesias, Jesús (Frontiers Media S.A., 2022)Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the ...
-
Artículo
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
López-Cortes, Luis Eduardo; Delgado-Valverde, Mercedes; Moreno-Mellado, Elisa; Goikoetxea Aguirre, Josune; Guio Carrión, Laura; Blanco Vidal, María José; López Soria, Leyre Mónica; Retamar Gentil, Pilar; Rodríguez-Baño, Jesús; SIMPLIFY study group (Elsevier, 2024) -
Artículo
Impact of De-escalation on Prognosis of Patients With Bacteremia due to Enterobacteriaceae: A Post Hoc Analysis From a Multicenter Prospective Cohort
Palacios-Baena, ZR; Delgado-Valverde, Mercedes; Mendez, AV; Almirante, Benito; Gomez-Zorrilla, S; Borrell, N; Corzo Delgado, Juan Enrique; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús; Cueto López, Marina de; Lepe Jiménez, José Antonio; Cisneros, José Miguel; Lara, R (Oxford University Press, 2019)Background More data are needed about the safety of antibiotic de-escalation in specific clinical situations as a ...
-
Artículo
Population pharmacokinetics of piperacillin in non-critically ill patients with bacteremia caused by enterobacteriaceae
Merino Bohórquez, Vicente; Docobo Pérez, Fernando; Valiente-Méndez, Adoración; Delgado-Valverde, Mercedes; Cameán, Manuel; Hope, William W.; Rodríguez-Baño, Jesús (MDPI, 2021-03-25)This study analyzes the pharmacokinetic variability of piperacillin in non-critically ill patients with Enterobacteriaceae ...